documents: FDA-1995-S-0039-0069

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1995-S-0039-0069 FDA FDA-1995-S-0039 Report 322 - Appendix I - "Metabolic pathway of SDG conversion to Enterolactone (EL) and Enterodiol (ED) " - [Archer Daniels Midland Company - BeneFlax Flax Lignans] Supporting & Related Material RPT-Report (Supporting and Related Material) 2008-10-23T04:00:00Z 2008 10     2016-09-30T14:22:32Z   0 0 090000648055f2be

Links from other tables